切换至 "中华医学电子期刊资源库"
高级检索
中华产科急救电子杂志

中华产科急救电子杂志 ›› 2014, Vol. 03 ›› Issue (04) : 276 -279. doi: 10.3877/cma.j.issn.2095-3259.2014.04.013

所属专题： 文献；

论著

三维计算机体层摄影血管成像超选择动脉栓塞术治疗胎盘植入的临床分析
覃亦伟1,†(), 张晓丽1   
  1. 1. 510800　广州，南方医科大学附属花都医院围产医学中心
  • 收稿日期:2014-05-28 出版日期:2014-11-18
  • 通信作者: 覃亦伟

Clinical analysis of three-dimensional computerized tomography angiography super selective uterine artery embolization in treating placenta increta

Yiwei Qin1,†(), Xiaoli Zhang1   

  1. 1. Department of Obstetrics and Gynecology, Huadu Hospital Affiliated to Southern Medical University, Guangzhou 510800, China
  • Received:2014-05-28 Published:2014-11-18
  • Corresponding author: Yiwei Qin
  • About author:
    Corresponding author: Qin Yiwei, Email:
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

覃亦伟, 张晓丽. 三维计算机体层摄影血管成像超选择动脉栓塞术治疗胎盘植入的临床分析[J]. 中华产科急救电子杂志, 2014, 03(04): 276-279.

Yiwei Qin, Xiaoli Zhang. Clinical analysis of three-dimensional computerized tomography angiography super selective uterine artery embolization in treating placenta increta[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2014, 03(04): 276-279.

目的

探讨三维计算机体层摄影血管成像(computerized tomography angiography, CTA)超选择胎盘植入的供血动脉栓塞治疗胎盘植入患者的治疗效果。

方法

收集并分析2010年2月至2013年12月就诊于南方医科大学附属花都医院围产医学中心70例胎盘植入患者的临床资料，35例患者应用三维CTA超选择胎盘植入的供血动脉栓塞为实验组，35患者例选择子宫动脉栓塞为对照组，对两组患者的术前一般情况、术中、术后及预后情况进行比较。

结果

实验组胎盘组织排出时间为(7.05±1.28) d、术后β-hCG为(5.35±0.67) U/L、术后出血量为(9.78±0.34) ml，对照组胎盘组织排出时间为(12.36±1.95) d、术后β-hCG为(6.97±0.99 )U/L、术后出血量为(15.22±1.96)ml，两组患者各项临床检测指标比较，t值分别为4.102，4.009，4.135，P均<0.01，差异有统计学意义。实验组无患者发生宫腔感染，但对照组有3例。

结论

三维CTA辅助下行超选择胎盘植入的供血动脉治疗胎盘植入具有安全、微创、止血迅速、可保留子宫等优点，有较高的临床应用价值。

关键词: 胎盘，侵入性, 栓塞，治疗性, 三维CTA, 结果评价
Objective

To evaluate the clinical efficacy of three-dimensional computerized tomography angiography(CTA) super selective supplying artery embolization in treating placenta increta; The supplying artery is for placenta increta.

Methods

The clinical data of 70 placenta increta patients were collected in Huadu Hospital Affiliated to Southern Medical University from February 2010 to December 2013. The patients were divided into two groups: 35 patients with three-dimensional CTA super selective artery embolization were in the treatment group, 35 patients with uterine artery embolization were in the control group. The clinical condition about patients during preoperative, intraoperative, and postoperative and prognosis of two groups were compared.

Results

In the treatment group, the time of placental tissue discharge were (7.05±1.28) days, the level of β-human chorionic gonadotropin(β-hCG) was (5.35±0.67) U/L, and the amount of postoperative bleeding was (9.78±0.34)ml. In the control group, the data were (12.36±1.95) days, (6.97±0.99)U/L, and (15.22±1.96)ml, respectively. There were significant differences in the two groups; t=4.102, 4.009, and 4.135 (all P value<0.01). There was none patient had uterus cavity infection in control group, but there were 3 patients had uterus cavity infection in treatment group.

Conclusions

The advantages of three-dimensional CTA super selective uterine artery embolization are safe, mini-invasive, stopping bleeding quickly, and reserving uterine for placenta increta patients. The therapeutic method has high clinical application value.

Key words: Placenta accreta, Embolization, therapeutic, Three-dimensional CTA, Outcome assessment
表1 两组患者术前一般资料比较(±s)
组别 例数 β-hCG水平(U/L) 累计术前出血量(ml) 术前收缩压(mmHg) 术前舒张压(mmHg)
实验组 35 3 660±285 1 530±340 98±13 63±17
对照组 35 3 592±297 1 670±261 92±14 59±15
t值 ? 1.621 1.532 1.590 1.615
P值 ? >0.05 >0.05 >0.05 >0.05
图1 三维CTA构建出子宫动静脉及属支。A：子宫动静脉及属支；B：植入性胎盘的供血动脉(箭头所指为子宫动脉卵巢支及输卵管支)
表2 两组患者术中情况比较(±s)
组别 例数 介入治疗时间(min) 曝光时间(s) 造影剂剂量(ml) 造影剂速率(ml/s)
实验组 35 30.37±9.22 11.70±1.55 1.5±0.21 3.12±0.27
对照组 35 40.95±11.96 18.14±1.87 2.0±0.97 4.00±0.33
t值 ? 4.233 4.156 4.178 4.210
P值 ? <0.01 <0.01 <0.01 <0.01
图2 胎盘植入患者栓塞术前及术后DSA造影图像。A：胎盘造影剂充盈显著，无外溢(箭头所指); B：子宫动脉增粗，植入性胎盘供血动脉分支多(箭头所指); C：对照组明胶海绵颗粒栓塞后，子宫动脉充盈减少(箭头所指); D：实验组明胶海绵颗粒栓塞后，对于子宫动脉基本无影响(箭头所指)
表3 两组患者术后指标的比较(±s)
组别 例数 胎盘排出时间(d) 术后β-hCG(U/L) 术后出血量(ml)
实验组 35 7.05±1.28 5.35±0.67 9.78±0.34
对照组 35 12.36±1.95 6.97±0.99 15.22±1.96
t值 ? 4.102 4.009 4.135
P值 ? <0.01 <0.01 <0.01
表4 两组患者预后情况的比较
组别 例数 β-hCG恢复正常时间(d，±s) 月经异常 宫腔感染
例数 百分比(%) 例数 百分比(%)
实验组 35 8.02±0.36 1 2.9 0 0
对照组 35 13.94±1.87 3 8.5 3 8.5
统计值 ? t＝4.576 χ2＝4.553 χ2＝4.591
P值 ? <0.01 <0.01 <0.01
[1]
Thadhani R, Kisner T, Hagmann H, et al. Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia[J]. Circulation, 2011, 124(8): 940-950.
[2]
刘萍，余艳红，陈春林，等. 基于CT扫描的计算机三维重建在女性骨盆研究中的方法和应用[J]. 中国实用妇科与产科杂志，2010, 26(1):35-38.
[3]
Garmi G, Salim R. Epidemiology, etiology, diagnosis, and management of plcenta accreta[J]. Obstet Gynecol Int, 2012, 2012:873929.
[4]
George EM, Arany M, Cockrell K, et al. Induction of heme oxygenase-1 attenuates sFlt-1-induced hypertension in pregnant rats[J]. Am J Physiol Regul Integr Comp Physiol, 2011, 301(5):R1495-R1500.
[5]
George EM, Cockrell K, Aranay M, et al. Induction of heme oxygenase 1 attenuates placental ischemia-induced hypertension[J]. Hypertension, 2011, 57(5):941-948.
[6]
Yu J, Shixia CZ, Wu Y, et al. Inhibin A, activin A, placental growth factor and uterine artery Doppler pulsatility index in the prediction of pre-eclampsia[J]. Ultrasound Obstet Gynecol, 2011, 37(5):528-533.
[7]
Mikat B, Zeller A, Scherag A, et al. βhCG and PAPP-A in first trimester：predictive factors for preeclampsia？[J]. Hypertens Pregnancy, 2012, 31(2):261-267.
[8]
Verlohren S, Herraiz I, Lapaire O, et al. The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients[J]. Am J Obstet Gynecol, 2012, 206(1):58.e1-e8.
[9]
Haddad B, Kayem G, Deis S, et al. Are perinatal and maternal outcomes different during expectant management of severe preeclampsia in the presence of intrauterine growth restriction[J]. Am J Obstet Gynecol, 2007, 196(3): 237.e1-e3.
[10]
Vaisbuch E, Romero R, Mazaki-Tovi S, et al. Retinol binding Protein 4-a novel association with early-onset preeclampsia[J]. J Perinat Med, 2010, 38(2):129-139.
[1] 李辉, 吴奇, 张子琦, 张晗, 王仿, 许鹏. 日间全膝关节置换术早期疗效及标准化流程探索[J]. 中华关节外科杂志(电子版), 2023, 17(06): 889-892.
[2] 陈代娟, 徐金凤, 田园, 王晓东, 彭冰. 凶险性前置胎盘术前评估及手术诊治研究现状[J]. 中华妇幼临床医学杂志(电子版), 2020, 16(06): 634-640.
[3] 汤斐, 周勇, 赵云. 环子宫下段缝合术治疗凶险性前置胎盘伴胎盘植入性疾病的临床疗效[J]. 中华妇幼临床医学杂志(电子版), 2020, 16(02): 239-244.
[4] 刘建, 李娅, 李俊鹏, 李易. 产前MRI在胎盘植入性疾病诊断中的应用价值[J]. 中华妇幼临床医学杂志(电子版), 2020, 16(02): 196-201.
[5] 张宇, 余灵祥, 杨永平, 赵德希, 刁广浩, 杨木易, 赵亮, 刘佳, 李鹏, 张宁, 任辉. 原发性肝癌Ⅲa期降期后肝切除临床疗效分析[J]. 中华肝脏外科手术学电子杂志, 2024, 13(01): 78-82.
[6] 崔佳琪, 吴迪, 陈海艳, 周惠敏, 顾元龙, 周光文, 杨军. TACE术后并发肝脓肿的临床诊治分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 688-693.
[7] 孟泓宇, 卢逸, 曹彦龙, 戴操, 杨佳伟, 林楠, 徐见亮. 基于PSM比较TACE联合射频消融与单纯射频消融治疗小肝癌疗效[J]. 中华肝脏外科手术学电子杂志, 2023, 12(04): 417-421.
[8] 卢文峰, 付雍, 阎凯, 袁建勇, 陈佩钦, 张海斌. 术后预防性TACE对肝内胆管细胞癌患者预后的影响[J]. 中华肝脏外科手术学电子杂志, 2022, 11(03): 268-272.
[9] 张凡, 汪学艳, 白琪, 王博方, 李玉民, 陈昊. 肝门部胆管癌术前评估和处理[J]. 中华肝脏外科手术学电子杂志, 2021, 10(05): 446-448.
[10] 曹耿飞, 张海潇, 顾俊鹏, 朱帝文, 鲍应军, 阿斯哈尔·哈斯木, 任伟新. 载药微球栓塞联合索拉非尼治疗不可切除肝癌安全性和疗效[J]. 中华肝脏外科手术学电子杂志, 2021, 10(01): 43-47.
[11] 李一帆, 顾俊鹏, 纪卫政, 张海潇, 朱帝文, 任伟新. TACE联合RFA治疗BCLC中晚期肝癌患者预后的影响因素分析[J]. 中华肝脏外科手术学电子杂志, 2020, 09(06): 557-561.
[12] 张发林, 雍昉. 应用空白微球行TACE治疗肝癌临床疗效分析[J]. 中华肝脏外科手术学电子杂志, 2020, 09(04): 339-342.
[13] 李清汉, 甄作均, 陈应军, 司徒翠瑶. 肝细胞癌破裂出血的治疗[J]. 中华肝脏外科手术学电子杂志, 2020, 09(03): 260-263.
[14] 刘允怡, 赖俊雄. 肝癌微创介入治疗[J]. 中华肝脏外科手术学电子杂志, 2020, 09(03): 201-205.
[15] 王丽霞, 粱锌, 葛玉龙, 欧阳超珩. 肿瘤专科医院特需门诊信息化管理与患者就诊满意度相关性研究[J]. 中华结直肠疾病电子杂志, 2021, 10(04): 441-444.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号